Department of Internal Medicine and Clinical Investigation Centre, Montpellier University Hospital, Montpellier University, Montpellier, France.
Department of General Internal Medicine, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada.
Thromb Haemost. 2018 Feb;118(2):320-328. doi: 10.1160/TH17-08-0598. Epub 2018 Jan 29.
In patients with deep-vein thrombosis (DVT) in the lower limbs, venous ulcer is the most debilitating and end-stage clinical expression of the post-thrombotic syndrome (PTS). To date, risk factors for PTS-related ulcer in DVT patients have not been identified.We used the international observational RIETE registry to assess the evolution of PTS signs and symptoms during a 3-year follow-up period and to identify independent predictors of PTS ulcer at 1 year in patients with acute DVT.Among 1,866 eligible patients, cumulative rates of PTS ulcer at 1, 2 and 3 years were 2.7% ( = 50), 4.3% ( = 54) and 7.1% ( = 60), respectively. The proportion of patients with PTS symptoms at 1, 2 or 3 years remained stable (≈40%), while the proportion of patients with PTS signs increased slightly over time (from 49 to 53%). Prior history of venous thromboembolism (VTE) (odds ratio [OR] = 5.5 [2.8-10.9]), diabetes (OR = 2.3 [1.1-4.7]), pre-existing leg varicosities (OR = 3.2 [1.7-6.1]) and male sex (OR = 2.5 [1.3-5.1]) independently increased the risk of PTS ulcer at 1 year. Obesity also increased the risk but failed to reach statistical significance (OR = 1.8 [0.9-3.3]). DVT treatment characteristics (duration or drug) did not influence the risk.Our results evidence that after acute DVT, pre-existing leg varicosities, prior venous thromboembolism, diabetes and male gender independently increased the risk for PTS ulcer. This suggests that clinicians should consider strategies aimed to prevent ulcers in high-risk DVT patients, such as preventing VTE recurrence, use of stockings in those with pre-existing venous insufficiency, careful monitoring of diabetic patients and encouraging weight loss in obese patients.
在下肢深静脉血栓形成(DVT)患者中,静脉溃疡是血栓后综合征(PTS)最具致残性和终末期的临床表现。迄今为止,尚未确定 DVT 患者 PTS 相关溃疡的危险因素。我们使用国际观察 RIETE 登记处来评估 PTS 体征和症状在 3 年随访期间的演变,并确定急性 DVT 患者在 1 年内 PTS 溃疡的独立预测因素。在 1866 名合格患者中,1 年、2 年和 3 年 PTS 溃疡的累积发生率分别为 2.7%(50 例)、4.3%(54 例)和 7.1%(60 例)。1 年、2 年或 3 年内 PTS 症状患者的比例保持稳定(≈40%),而 PTS 体征患者的比例随时间略有增加(从 49%增加到 53%)。静脉血栓栓塞症(VTE)既往史(比值比[OR] = 5.5 [2.8-10.9])、糖尿病(OR = 2.3 [1.1-4.7])、预先存在的腿部静脉曲张(OR = 3.2 [1.7-6.1])和男性(OR = 2.5 [1.3-5.1])独立增加了 1 年内 PTS 溃疡的风险。肥胖也增加了风险,但未达到统计学意义(OR = 1.8 [0.9-3.3])。DVT 治疗特征(持续时间或药物)并不影响风险。我们的研究结果表明,在急性 DVT 后,预先存在的腿部静脉曲张、先前的静脉血栓栓塞、糖尿病和男性独立增加了 PTS 溃疡的风险。这表明,临床医生应考虑针对高危 DVT 患者预防溃疡的策略,例如预防 VTE 复发、对存在静脉功能不全的患者使用弹力袜、仔细监测糖尿病患者并鼓励肥胖患者减肥。